Hi, help us enhance your experience
Hi, help us enhance your experience
Hi, help us enhance your experience
1354 Views
eMediNexus 11 March 2018
Lenalidomide may be an alternative (off-label) to thalidomide for the treatment of recurrent erythema multiforme as reported in a series of three cases published online February 14, 2018 in JAMA Dermatology. Adverse events may limit the use of thalidomide as long-term treatment.
{{Article_Title}}
{{Article_Author}}
{{Article_Title}}
{{Article_Author}}
{{Article_Title}}..
Adherence Challenges in Hypertension Management: Opportunity for Packa.....
Radiological Clues to Pulmonary TB with Pleural Effusion on Chest CT..
CONFIDENCE in Combination Therapy for CKD and Type 2 Diabetes..
Higher Muscle Mass Lowers Risk of Incident Type 2 Diabetes..
Unmasking Barriers to Adult Immunization..